5-MeO-DMT Imaging

  • Research type

    Research Study

  • Full title

    Human brain effects of intranasal 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT)

  • IRAS ID

    302769

  • Contact name

    David Erritzoe

  • Contact email

    d.erritzoe@imperial.ac.uk

  • Sponsor organisation

    Imperial College London

  • Clinicaltrials.gov Identifier

    NA, NA

  • Duration of Study in the UK

    3 years, 0 months, 1 days

  • Research summary

    The main objective of the present study is to investigate the effects of 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) on human brain activity of healthy participants by using high-density electroencephalography(HD-EEG). The aim is to learn how 5-MeO-DMT changes brain activity to alter consciousness, which is part of a broader initiative to utilize hallucinogenic substances as tools to probe and thereby better understand brain function and its relationship to consciousness

  • REC name

    London - Brent Research Ethics Committee

  • REC reference

    22/LO/0231

  • Date of REC Opinion

    5 May 2022

  • REC opinion

    Further Information Favourable Opinion